S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AbbVieAbbott LaboratoriesNovartisMerck & Co., Inc.Pfizer
SymbolNYSE:ABBVNYSE:ABTNYSE:NVSNYSE:MRKNYSE:PFE
Price Information
Current Price$110.86$112.84$96.90$80.98$36.55
52 Week RangeBuyBuyHoldBuyHold
MarketRank™
Overall Score2.82.42.02.22.7
Analysis Score1.41.43.22.42.1
Community Score2.92.72.32.52.9
Dividend Score5.04.22.52.53.3
Ownership Score1.71.70.01.73.3
Earnings & Valuation Score3.11.91.91.91.9
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyHold
Consensus Price Target$112.50$115.69$114.00$95.36$40.07
% Upside from Price Target1.48% upside2.52% upside17.65% upside17.75% upside9.63% upside
Trade Information
Market Cap$195.72 billion$199.99 billion$221.78 billion$204.88 billion$203.16 billion
Beta0.840.830.590.430.7
Average Volume7,535,6194,907,3951,853,6589,904,50134,240,930
Sales & Book Value
Annual Revenue$33.27 billion$31.90 billion$47.50 billion$46.84 billion$51.75 billion
Price / Sales5.886.274.674.373.93
Cashflow$10.36 per share$5.06 per share$8.20 per share$6.58 per share$4.07 per share
Price / Cash10.7022.3111.8212.318.97
Book Value($5.53) per share$17.70 per share$24.53 per share$10.21 per share$11.46 per share
Price / Book-20.056.383.957.933.19
Profitability
Net Income$7.88 billion$3.69 billion$11.73 billion$9.84 billion$16.27 billion
EPS$8.94$3.24$5.24$5.19$2.95
Trailing P/E Ratio23.4459.7031.3617.9223.58
Forward P/E Ratio9.1125.7614.8613.3411.94
P/E Growth1.542.061.761.892.79
Net Margins18.16%10.50%14.71%24.33%17.85%
Return on Equity (ROE)439.24%18.19%24.39%53.83%24.88%
Return on Assets (ROA)13.22%8.29%10.59%16.83%9.32%
Dividend
Annual Payout$5.20$1.80$2.01$2.60$1.52
Dividend Yield4.69%1.60%2.07%3.21%4.16%
Three-Year Dividend Growth84.37%35.85%N/A31.22%-10.94%
Payout Ratio58.17%55.56%38.36%50.10%51.53%
Years of Consecutive Dividend Growth49 Years49 YearsN/A1 Years1 Years
Debt
Debt-to-Equity Ratio5.38%0.58%0.49%0.90%0.76%
Current Ratio0.95%1.70%0.91%1.30%1.40%
Quick Ratio0.81%1.19%0.69%1.00%1.13%
Ownership Information
Institutional Ownership Percentage67.49%72.58%9.86%72.86%67.36%
Insider Ownership Percentage0.09%1.70%0.01%0.28%0.08%
Miscellaneous
Employees30,000107,000103,91471,00088,300
Shares Outstanding1.77 billion1.77 billion2.29 billion2.53 billion5.56 billion
Next Earnings Date2/3/2021 (Confirmed)1/27/2021 (Confirmed)1/26/2021 (Confirmed)2/4/2021 (Confirmed)2/2/2021 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.